Global in vitro diagnostics market share by top medtech companies 2016 and 2022

The data represents the top 10 medical technology companies for in vitro diagnostics in 2016 and 2022, based on market share. In 2016, Sysmex accounted for 4.3% of the global market for in vitro diagnostics. By 2022, this share is expected to increase to over 5%. In vitro diagnostics allows for medical professionals to detect diseases, conditions, and infections. These tests can be conducted within a laboratory and sometimes at within a patient's home.